Use of Tyrosine Kinase Inhibitors to Prevent Relapse After Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Position Statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

S Gebel; A Czyz; O Ottmann; F Baron; E Brissot; F Ciceri; Jan Cornelissen; J Esteve; NC Gorin; B Savani; C Schmid; M Mohty; A Nagler

doi:10.1002/cncr.30130

Use of Tyrosine Kinase Inhibitors to Prevent Relapse After Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Position Statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

S Gebel
, A Czyz
, O Ottmann
, F Baron
, E Brissot
, F Ciceri
, Jan Cornelissen
, J Esteve
, NC Gorin
, B Savani
, C Schmid
, M Mohty
, A Nagler

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

162 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2941-2951
Number of pages	11
Journal	Cancer
Volume	122
Issue number	19
DOIs	https://doi.org/10.1002/cncr.30130
Publication status	Published - 2016

Research programs

EMC MM-02-41-04

Access to Document

10.1002/cncr.30130

Cite this

Gebel, S., Czyz, A., Ottmann, O., Baron, F., Brissot, E., Ciceri, F., Cornelissen, J., Esteve, J., Gorin, NC., Savani, B., Schmid, C., Mohty, M., & Nagler, A. (2016). Use of Tyrosine Kinase Inhibitors to Prevent Relapse After Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Position Statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Cancer, 122(19), 2941-2951. https://doi.org/10.1002/cncr.30130

Gebel, S ; Czyz, A ; Ottmann, O et al. / Use of Tyrosine Kinase Inhibitors to Prevent Relapse After Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Position Statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. In: Cancer. 2016 ; Vol. 122, No. 19. pp. 2941-2951.

@article{8848511c1d97435c8781296fab41d1a2,

title = "Use of Tyrosine Kinase Inhibitors to Prevent Relapse After Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Position Statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation",

author = "S Gebel and A Czyz and O Ottmann and F Baron and E Brissot and F Ciceri and Jan Cornelissen and J Esteve and NC Gorin and B Savani and C Schmid and M Mohty and A Nagler",

year = "2016",

doi = "10.1002/cncr.30130",

language = "Undefined/Unknown",

volume = "122",

pages = "2941--2951",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley \& Sons Inc.",

number = "19",

}

Gebel, S, Czyz, A, Ottmann, O, Baron, F, Brissot, E, Ciceri, F, Cornelissen, J, Esteve, J, Gorin, NC, Savani, B, Schmid, C, Mohty, M & Nagler, A 2016, 'Use of Tyrosine Kinase Inhibitors to Prevent Relapse After Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Position Statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation', Cancer, vol. 122, no. 19, pp. 2941-2951. https://doi.org/10.1002/cncr.30130

Use of Tyrosine Kinase Inhibitors to Prevent Relapse After Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Position Statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. / Gebel, S; Czyz, A; Ottmann, O et al.
In: Cancer, Vol. 122, No. 19, 2016, p. 2941-2951.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Use of Tyrosine Kinase Inhibitors to Prevent Relapse After Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Position Statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

AU - Gebel, S

AU - Czyz, A

AU - Ottmann, O

AU - Baron, F

AU - Brissot, E

AU - Ciceri, F

AU - Cornelissen, Jan

AU - Esteve, J

AU - Gorin, NC

AU - Savani, B

AU - Schmid, C

AU - Mohty, M

AU - Nagler, A

PY - 2016

Y1 - 2016

U2 - 10.1002/cncr.30130

DO - 10.1002/cncr.30130

M3 - Article

C2 - 27309127

SN - 0008-543X

VL - 122

SP - 2941

EP - 2951

JO - Cancer

JF - Cancer

IS - 19

ER -

Gebel S, Czyz A, Ottmann O, Baron F, Brissot E, Ciceri F et al. Use of Tyrosine Kinase Inhibitors to Prevent Relapse After Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Position Statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Cancer. 2016;122(19):2941-2951. doi: 10.1002/cncr.30130